Pub. Date : 1997 Nov
PMID : 9351974
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The decreases in the inhibitory potencies on hPGHS-2(R106E) by the carboxylate-containing NSAIDs flurbiprofen, indomethacin, meclofenamic acid, and diclofenac on hPGHS-2(R106E) were 965-, 48-, 5.5-, and 4.5-fold, respectively. | Indomethacin | prostaglandin-endoperoxide synthase 2 | Homo sapiens |
2 | The nonuniversal requirement for interaction of the carboxylate group of certain NSAIDs with the Arg106 residue in hPGHS-2 is supported by the observation that the methyl ester derivative of indomethacin was a more potent inhibitor than indomethacin on both hPGHS-2 and hPGHS-2(R106E). | Indomethacin | prostaglandin-endoperoxide synthase 2 | Homo sapiens |
3 | The nonuniversal requirement for interaction of the carboxylate group of certain NSAIDs with the Arg106 residue in hPGHS-2 is supported by the observation that the methyl ester derivative of indomethacin was a more potent inhibitor than indomethacin on both hPGHS-2 and hPGHS-2(R106E). | Indomethacin | prostaglandin-endoperoxide synthase 2 | Homo sapiens |
4 | The nonuniversal requirement for interaction of the carboxylate group of certain NSAIDs with the Arg106 residue in hPGHS-2 is supported by the observation that the methyl ester derivative of indomethacin was a more potent inhibitor than indomethacin on both hPGHS-2 and hPGHS-2(R106E). | Indomethacin | prostaglandin-endoperoxide synthase 2 | Homo sapiens |
5 | The nonuniversal requirement for interaction of the carboxylate group of certain NSAIDs with the Arg106 residue in hPGHS-2 is supported by the observation that the methyl ester derivative of indomethacin was a more potent inhibitor than indomethacin on both hPGHS-2 and hPGHS-2(R106E). | Indomethacin | prostaglandin-endoperoxide synthase 2 | Homo sapiens |